DSL expands services with acquisition of OBI. (Industry Watch).* Diagnostic Systems Laboratories, Inc., Webster, TX, has acquired Oxford Bio-Innovation Ltd., a joint venture between Oxford Brookes University Oxford Brookes University is a public university in Oxford, England. Overview The University has roots in Oxford that go back to 1865 (when it was known as the Oxford School of Art). The present student body is 19,000. and Serotec Ltd. Based in Oxford, England, OBI develops, manufactures and markets diagnostic and research products for the measurement of Inhibin in·hib·in n. A peptide hormone secreted by the follicular cells of the ovary and the Sertoli cells of the testis that inhibits secretion of follicle stimulating hormone from the anterior pituitary. and Activin activin /ac·ti·vin/ (ak´ti-vin) a nonsteroidal regulator synthesized in the pituitary glands and gonads that stimulates the secretion of follicle-stimulating hormone. ac·ti·vin n. levels. The company also operates a clinical testing service focused on Inhibin and Activin level measurements, which play a crucial role in a number of challenging clinical issues including male infertility, assessment of ovarian reserve, prediction of IVF IVF in vitro fertilization. IVF abbr. in vitro fertilization IVF 1 In vitro fertilization, see there 2. Intravascular fluid outcomes, and differential diagnosis of ovarian cancer. These tests are used by numerous clinical and research laboratories worldwide. (Industry watch) |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion